Related Experiment Videos
Update on Charcot neuroarthropathy.
1Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. ejude@dc.cmht.nwest.nhs.uk
Current Diabetes Reports
|March 20, 2003
Summary
Diabetic Charcot neuroarthropathy, often mistaken for infections, requires early diagnosis in patients with peripheral neuropathy. This review discusses its causes and a recent trial investigating bisphosphonates for treatment.
Area of Science:
- Diabetology
- Neurology
- Orthopedics
Background:
- Charcot neuroarthropathy is a serious complication in diabetic patients with peripheral neuropathy.
- It is frequently misdiagnosed as cellulitis or osteomyelitis, leading to delayed treatment.
- Early recognition and intervention are crucial for managing this debilitating condition.
Purpose of the Study:
- To review the pathogeneses of diabetic Charcot neuroarthropathy.
- To summarize recent research on its etiopathogenetic factors.
- To report on a multicenter trial using bisphosphonates for treatment.
Main Methods:
- Literature review of pathogeneses and recent studies.
- Description of a completed multicenter trial.
Main Results:
- The article covers the underlying mechanisms of Charcot neuroarthropathy.
- Recent studies have shed light on its etiopathogenetic factors.
- A multicenter trial on bisphosphonate use in this condition has been completed.
Conclusions:
- A high index of suspicion is necessary for early diagnosis of diabetic Charcot neuroarthropathy.
- Understanding the pathogeneses aids in early and appropriate treatment.
- Bisphosphonates represent a potential therapeutic option being investigated.